Sutro BioPharma, Inc.
NASDAQ: STROSouth San Francisco, US · Delaware corporation · 1 known investors
Clinical-stage company developing next generation antibody drug conjugates for cancer treatment using proprietary cell-free protein manufacturing technology.
Biotech
Founders & leadership
JL
Joseph LobackiDirector
DJ
Daniel JanneyDirector
AS
Armen ShanafeltDirector
VB
Virgil Bryan LawlisDirector
JG
John G. FreundDirector
WJ
William J. NewellExecutive Officer, Director
MD
Michael DybbsDirector
MR
Michael RossDirector
DP
Daniel PetreeDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$85.4MraisedAug 2018 · 15 investors · BiotechnologyRule 506(b)
▶$85.4MraisedAug 2018 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph LobackiDirector
- Daniel JanneyDirector
- Armen ShanafeltDirector
- Virgil Bryan LawlisDirector
- John G. FreundDirector
- William J. NewellExecutive Officer, Director
- Michael DybbsDirector
- Michael RossDirector
- Daniel PetreeDirector
- Offering amount
- $85.4M
- Amount sold
- $85.4M
- First sale
- May 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.